HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) All Versions of this Article: thx.2005.043026v1 60/10/865    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, C Articles by Corris, P A Search for Related Content PubMed PubMed Citation Articles by Ward, C Articles by Corris, P A Topic Collections Relevant Article

Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients

¹ Applied Immunobiology and Transplantation Research Group, Faculty of Medical Sciences, Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK
² Musculoskeletal Research Group, Faculty of Medical Sciences, Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK

Correspondence to:
Correspondence to:
Professor P A Corris
Applied Immunobiology and Transplantation Research Group, Faculty of Medical Sciences, Medical School, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK; paul.corris{at}ncl.ac.uk

Background: Obliterative bronchiolitis in chronic rejection of lung allografts is characterised by airway epithelial damage and fibrosis. The process whereby normal epithelium is lost and replaced by fibroblastic scar tissue is poorly understood, but recent findings suggest that epithelial cells can become fibroblasts through epithelial-mesenchymal transition (EMT). It is hypothesised that EMT occurs in lung allografts and plays a potential role in airway remodelling.

Methods: Sixteen stable lung transplant recipients underwent bronchoscopy with bronchoalveolar lavage (BAL), endobronchial biopsies, and bronchial brushings. Biopsy sections were stained for the fibroblast marker S100A4. Brushings were cultured on collagen, stained with anti-S100A4, and examined for further EMT markers including matrix metalloproteinase (MMP) zymographic activity and epithelial invasion through collagen coated filters.

Results: A median 15% (0–48%) of the biopsy epithelium stained for S100A4 in stable lung transplant recipients and MMP-7 co-localisation was observed. In non-stimulated epithelial cultures from lung allografts, S100A4 staining was identified with MMP-2 and MMP-9 production and zymographic activity. MMP total protein and activity was increased following stimulation with transforming growth factor (TGF)-ß₁. Non-stimulated transplant epithelial cells were invasive and penetration of collagen coated filters increased following TGF-ß₁ stimulation.

Conclusions: This study provides evidence of EMT markers in lung allografts of patients without loss of lung function. The EMT process may represent a final common pathway following injury in more common diseases characterised by airway remodelling.

Abbreviations: BAL, bronchoalveolar lavage; BOS, bronchiolitis obliterans syndrome; EBB, endobronchial biopsy; EMT, epithelial-mesenchymal transition; IL, interleukin; MMP, matrix metalloproteinase; NK, natural killer; OB, obliterative bronchiolitis; PBEC, primary bronchial epithelial cell; TGF-ß₁, transforming growth factor ß₁

Keywords: lung transplantation; epithelial-mesenchymal transition

Relevant Article

Airwaves

Wisia Wedzicha
Thorax 2005 60: 793. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				D. M. Murphy, I. A. Forrest, P. A. Corris, G. E. Johnson, T. Small, D. Jones, A. J. Fisher, J. J. Egan, T. E. Cawston, C. Ward, et al. Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L592 - L599. [Abstract] [Full Text] [PDF]

				E. H. Walters, D. W. Reid, D. P. Johns, and C. Ward Nonpharmacological and pharmacological interventions to prevent or reduce airway remodelling Eur. Respir. J., September 1, 2007; 30(3): 574 - 588. [Abstract] [Full Text] [PDF]

				D. M Murphy, I. A Forrest, C. Ward, P. A Corris, G. E Johnson, D. Jones, A. J Fisher, J. J Egan, T. E Cawston, and J. L Lordan Effect of azithromycin on primary bronchial epithelial cells derived from stable lung allografts Thorax, September 1, 2007; 62(9): 834 - 834. [Full Text] [PDF]

				B. C. Willis and Z. Borok TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L525 - L534. [Abstract] [Full Text] [PDF]

				M. M. Myerburg, J. D. Latoche, E. E. McKenna, L. P. Stabile, J. S. Siegfried, C. A. Feghali-Bostwick, and J. M. Pilewski Hepatocyte growth factor and other fibroblast secretions modulate the phenotype of human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1352 - L1360. [Abstract] [Full Text] [PDF]

				P. A. Corris and J. D. Christie Update in Transplantation 2006 Am. J. Respir. Crit. Care Med., March 1, 2007; 175(5): 432 - 435. [Full Text] [PDF]

				M. Estenne and R. M. Kotloff Update in transplantation 2005. Am. J. Respir. Crit. Care Med., March 15, 2006; 173(6): 593 - 598. [Full Text] [PDF]

				B. C. Willis, R. M. duBois, and Z. Borok Epithelial Origin of Myofibroblasts during Fibrosis in the Lung. Proceedings of the ATS, January 1, 2006; 3(4): 377 - 382. [Abstract] [Full Text] [PDF]